CAR T cell therapy
| 2 min read
Researchers revealed for the first time that CAR T cells can transfer their CAR molecules to regular T cells in a process known as trogocytosis.
| 3 min read
Ovarian tumors are extremely difficult to get rid of. Scientists are figuring out how to leverage the immune system to help.
| 5 min read
Industry leaders predict the most exciting advances in drug discovery and development in the coming year.
| 4 min read
Bristol Myers Squibb unveiled promising CAR T cell therapy data for severe autoimmune diseases from their Phase 1 clinical trial, offering hope for remission.
| 10 min read
A modular CAR T cell could make cancer therapy safer and more effective.
| 9 min read
This year’s laureates have made groundbreaking discoveries from unlocking the secrets of DNA to fighting enteric diseases and cancer.
| 3 min read
CRISPR-edited immune cells may help patients with T-cell leukemia, albeit with immunotherapy-related risks.
Page 1 of 1 - 7 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
